Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company known for its cystic fibrosis (CF) treatments, is at a critical juncture as it seeks to diversify its portfolio and maintain its ...

In Q2FY25, Walchandnagar's revenue was at Rs 73.44 crore, around 16.5% than a year ago, with a PBT loss of Rs 11.03 crore in ...